UBE2D2 and UBE2V2 were predicted to be two possible mRNA targets of miR-193a-5p in our bioinformatics analysis, and the upregulated expression of both was validated in neutrophils of AIS patients. The gene discussed is UBE2V2; the disease is androgen insensitivity syndrome.